Transcatheter aortic valve implantation (TAVI) is a less invasive aortic valve replacement technique and is indicated for patients with symptomatic severe aortic stenosis and a high operative risk. Cerebral embolisation seems inherent to TAVI, as illustrated by the consistent appearance of new brain lesions on post-procedural MRI studies. Embolic protection devices may capture or deflect embolised material en route to the brain and thus reduce TAVI-related brain injury. Histopathology studies of captured debris revealed a diverse aetiology including recent or organised thrombotic material, tissue originating from the aortic valve, atherosclerotic plaques or myocardium and foreign body components. In this overview we provide a perspective on current evidence and implications for embolic protection devices in the dynamic TAVI field.

Additional Metadata
Keywords Aortic stenosis, Embolic protection device, Transcatheter aortic valve implantation
Persistent URL,
Journal Interventional Cardiology (London)
Rights No subscription
Kroon, H.G, & van Mieghem, N.M. (2017). Need for embolic protection during transcatheter aortic valve implantation: An interventionalist's perspective on histopathology findings. Interventional Cardiology (London), 12(1), 36–39. doi:10.15420/icr.2016:30:2